A phase 2 study showed antitumor activity with the addition of the ataxia telangiectasia and Rad3-related kinase inhibitor berzosertib to topotecan.
Domain | berzosertibinhibitor.com |
---|---|
Homepage URL | https://berzosertibinhibitor.com/side-line-blood-vessels-micrornas-and-also-the-covid-19-affected-individual-methodological-factors-technological/ |
Keywords | berzosertib inhibitor potassium channel immunisation coverage |
Sprache | englisch |